StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) stock

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3036% below fair value
$3.05−0.06 (-1.93%)

Close on Nov 20, 2026Market cap $445.07MP/E –Yield –

MiMedx net income

Net income is the profit left for shareholders after every expense, interest and tax.

MiMedx's net income for the twelve months ending Sep 30, 2026 was -$19.19M, down 147.0% year over year. For fiscal 2025 it was $48.58M, up 14.5% from the year before. Over ten years it grew 5.1% a year on average. The highest annual figure on record is $64.73M in fiscal 2017.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$48.58M+14.5%
FY2024Dec 31, 2024$42.42M-27.2%
FY2023Dec 31, 2023$58.23M–
FY2022Dec 31, 2022-$30.20M–
FY2021Dec 31, 2021-$10.29M–
FY2020Dec 31, 2020-$49.28M–
FY2019Dec 31, 2019-$25.58M–
FY2018Dec 31, 2018-$29.98M-146.3%
FY2017Dec 31, 2017$64.73M+16496.7%
FY2016Dec 31, 2016$390.00K-98.7%
FY2015Dec 31, 2015$29.45M+373.4%
FY2014Dec 31, 2014$6.22M–
FY2013Dec 31, 2013-$4.11M–
FY2012Dec 31, 2012-$7.66M–
FY2011Dec 31, 2011-$10.19M–
FY2010Dec 31, 2010-$11.42M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$8.68M-151.8%
Q2 FY2026Jun 30, 2026-$14.84M-254.3%
Q1 FY2026Mar 31, 2026-$10.86M-254.6%
Q4 FY2025Dec 31, 2025$15.19M+104.2%
Q3 FY2025Sep 30, 2025$16.75M+106.9%
Q2 FY2025Jun 30, 2025$9.62M-45.4%
Q1 FY2025Mar 31, 2025$7.02M-24.2%
Q4 FY2024Dec 31, 2024$7.44M-86.1%
Q3 FY2024Sep 30, 2024$8.10M-5.1%
Q2 FY2024Jun 30, 2024$17.63M+1368.8%
Q1 FY2024Mar 31, 2024$9.26M–
Q4 FY2023Dec 31, 2023$53.48M–
Q3 FY2023Sep 30, 2023$8.53M–
Q2 FY2023Jun 30, 2023$1.20M–
Q1 FY2023Mar 31, 2023-$4.98M–
Q4 FY2022Dec 31, 2022-$414.00K-118.7%
Q3 FY2022Sep 30, 2022-$8.43M–
Q2 FY2022Jun 30, 2022-$10.87M–
Q1 FY2022Mar 31, 2022-$10.49M–
Q4 FY2021Dec 31, 2021$2.22M–
Q3 FY2021Sep 30, 2021-$2.34M–
Q2 FY2021Jun 30, 2021-$1.78M–
Q1 FY2021Mar 31, 2021-$8.38M–
Q4 FY2020Dec 31, 2020-$16.58M–
Q3 FY2020Sep 30, 2020-$19.42M-256.9%
Q2 FY2020Jun 30, 2020-$8.47M–
Q1 FY2020Mar 31, 2020-$4.82M–
Q4 FY2019Dec 31, 2019-$7.48M–
Q3 FY2019Sep 30, 2019$12.38M–
Q2 FY2019Jun 30, 2019-$17.21M-1054.0%
Q1 FY2019Mar 31, 2019-$13.27M-387.4%
Q4 FY2018Dec 31, 2018-$36.22M-947.1%
Q3 FY2018Sep 30, 2018-$178.00K-100.4%
Q2 FY2018Jun 30, 2018$1.80M-82.7%
Q1 FY2018Mar 31, 2018$4.62M-23.0%
Q4 FY2017Dec 31, 2017$4.28M-22.0%
Q3 FY2017Sep 30, 2017$44.05M–
Q2 FY2017Jun 30, 2017$10.40M–
Q1 FY2017Mar 31, 2017$6.00M–
Q4 FY2016Dec 31, 2016$5.48M–

More MiMedx figures

See a number that looks wrong?